Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04019613 · ClinicalTrials.gov registry record · NA
Assessment of Pulmonary Congestion During Cardiac Hemodynamic Stress Testing
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04019613: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT04019613 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04019613, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The aim of this study is to utilize lung ultrasound to detect the development of extravascular lung water in patients undergoing clinically indicated invasive hemodynamic exercise stress testing for symptomatic shortness of breath. The study will correlate the lung ultrasound findings with cardiac hemodynamics and measurements of extravascular lung water in an effort to better understand the pathophysiology of exertional dyspnea.
Primary Outcome
Lung ultrasound will be performed during invasive stress testing. The number of B-lines visible during stress testing will be correlated with synchronous measurements of intra-cardiac filling pressures .
Interventions
- DIAGNOSTIC_TEST Lung ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-11-08 |
| Est. Completion | 2019-12-19 |
| Phase | NA |
Why NCT04019613 stopped before completion
NCT04019613 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Lung ultrasound is the first listed.
NCT04019613 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04019613 about?
NCT04019613 is a clinical study titled "Assessment of Pulmonary Congestion During Cardiac Hemodynamic Stress Testing". The aim of this study is to utilize lung ultrasound to detect the development of extravascular lung water in patients undergoing clinically indicated invasive hemodynamic exercise stress testing for symptomatic shortness of breath. The study will correlate the lung ultrasound findings with cardiac h...
What is the current status of trial NCT04019613?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2019-11-08. Estimated completion is 2019-12-19.
What interventions are being tested in trial NCT04019613?
The interventions under investigation include: Lung ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04019613?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04019613's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI